Medline Industries Recalls Over 926,000 IV Administration and Extension Sets Due to Connector Failure
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a voluntary recall for nearly 1 million IV administration and extension sets because male luer connectors may leak or break, posing serious health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on March 3, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP has initiated a voluntary recall of various IV Administration and Extension sets. The recall was prompted by findings that, under certain circumstances involving exposure to specific chemicals and mechanical forces, the male luer connectors on these devices may leak, crack, or break during use.
Which Products Are Affected
A total of 926,227 units are affected by this recall. The distribution includes nationwide coverage in the United States and the Bahamas. The recall includes all lot numbers for the following 23 model numbers:
- DYNDTB0529: DBD-IV ADMIN SET, 60DRP, 1 NEEDLE-FREE VALV
- DYNDTB1029: IV ADMIN SET, 10DRP, 1NF, 92
- DYNDTB1516: DBD-IVEXTSET 2.4ML 2 NEEDLE-FREE VLVE, 35
- DYNDTB1530: DBD-IV ADMIN SET, 15DRP, 1 INJECT PORT
- DYNDTB1539: DBD-IV ADMIN SET, 15DRP, ROLLER CLAMP, 6
- DYNDTB1545: DBD-IV ADMIN SET, 15DRP, 3 NF, 109
- DYNDTB2045: IV ADMIN SET, 20DRP, 3 NF, 109
- DYNDTB0512: DBD-IV ADMIN SET 60DRP 2 NEEDLE-FREE VLVE 96
- DYNDTB0555: DBD-IV ADMIN SET, 60DRP 3 NEEDLE-FREE VLVE 11
- DYNDTB1022: IV ADMIN SET, 10DRP, NF, INJ, 96
- DYNDTB1512: DBD-IV ADMIN SET, 15DRP, 2NF, 96
- DYNDTB1529: DBD-IV ADMIN SET, 15DRP, 1NF, 92
- DYNDTB1537: DBD-IV ADMIN SET, 15DRP, ROLLER CLAMP, 9
- DYNDTB1540: DBD-IV ADMIN SET, 15DRP, SECOND, 40
- DYNDTB2029: IV ADMIN SET, 20DRP, 1NF, 92
- DYNDTB5077: DBD-IV EXT SET, 6.5, 1.1ML, M LUERLOCK
- DYNDTB1045: IV ADMIN SET, 10DRP, 3 NF, 109
- DYNDTB1545D: DBD-IV ADMI SET 15DRP 4 NEEDLEFREE VLVESTPCK1
- DYNDTB2524: IV ADMIN SET 15DRP FLWCTRL 1 NEEDLEFREE VA
- DYNDTB1012: IV ADMIN SET, 10DRP, 2NF, 96
- DYNDTB2012: IV ADMIN SET, 20DRP, 2NF, 96
- DYNDTB2022: IV ADMIN SET, 20DRP, NF, INJ, 96
- DYNDTB5081: DBD-IV EXT SET, SMBORE EXT, 8, M LUERLOCK, 1
What You Should Do
Medline Industries, LP began notifying customers of the recall via a formal letter on December 31, 2025. Healthcare facilities and consumers should immediately check their inventory for the model numbers listed above. Affected products should be identified and handled according to the instructions provided in the firm's notification letter. For further assistance, contact Medline Industries, LP at their Northfield, IL headquarters.
Why This Matters
Failure of the male luer connectors can lead to serious medical complications, including blood loss, infection, air embolism, or the underdosage of critical medication. These failures can also result in significant delays in patient treatment.
Source
Information provided by the FDA. Recall Number: Z-1366-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category